top of page
Search

Low-Dose Amikacin as Alternative Treatment for Multidrug-Resistant Tuberculosis

Low-dose amikacin with appropriate dose adjustment based on adequate monitoring demonstrated limited toxicity with positive outcomes as a treatment option for multidrug-resistant tuberculosis (MDR-TB), according to the findings of a retrospective cohort study published in BMC Infectious Diseases. Read here
 
 
 

Recent Posts

See All

Comments


bottom of page